Internal Medicine, Gastroenterology · San Francisco, CA
NPI
1821040320
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
4
Medicare group memberships
Hospitals
1
Hospital affiliations
1701 Divisadero St, Suite 120
San Francisco, CA, 94115
Phone (415) 502-4444
Groups this clinician bills Medicare through
Medicare paid, 2024
$96K
1,919 services
Medicare patients, 2024
358
Average age 74
Drug cost, 2024
$1.8M
455 prescriptions
Company payments, 2024
$81.42
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jonathan P Terdiman was code 99215 (office e&m - established), 153 times for 112 patients. In total Jonathan P Terdiman billed 1,919 services in 39 codes, and Medicare paid $96K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-08-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 153 | 112 | $123.00 | $19K |
| G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 106 | 106 | $4.47 | $474 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 91 | 70 | $14.82 | $1,349 |
| 45385 Colonoscopy - Lesion Removal | Facility | 70 | 70 | $230.99 | $16K |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 47 | 47 | $199.65 | $9,384 |
| 45380 Lower GI Endoscopy - Other | Facility | 47 | 47 | $144.48 | $6,790 |
| 43239 Upper GI Endoscopy | Facility | 38 | 38 | $86.98 | $3,305 |
| 99205 Office E&M - New | Office | 31 | 31 | $156.53 | $4,852 |
| 43235 Upper GI Endoscopy | Facility | 24 | 24 | $73.09 | $1,754 |
| 99214 Office E&M - Established | Office | 16 | 14 | $78.04 | $1,249 |
| 45378 Lower GI Endoscopy - Other | Facility | 16 | 16 | $132.54 | $2,121 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 14 | 14 | $196.69 | $2,754 |
By year: 2022 $75K for 707 services; 2023 $79K for 1,231 services; 2024 $96K for 1,919 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jonathan P Terdiman prescribed most often to Medicare patients was Sodium Chloride (Sodium Chloride 0.45 %), with 53 prescriptions and refills. In total Jonathan P Terdiman wrote 455 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sodium Chloride Sodium Chloride 0.45 % | 53 | 53 | Under 11 | $7,255 |
| Pantoprazole Sodium Generic | 24 | 70 | 12 | $729 |
| Skyrizi On-Body Risankizumab-Rzaa | 23 | 43 | Under 11 | $476K |
| Xifaxan Rifaximin | 21 | 25 | 16 | $69K |
| Omeprazole Generic | 20 | 52 | 13 | $629 |
| Mesalamine Er Mesalamine | 18 | 29 | Under 11 | $13K |
| Famotidine Generic | 18 | 52 | 12 | $599 |
| Creon Lipase/Protease/Amylase | 15 | 32 | Under 11 | $42K |
| Sodium Chloride 0.9 % Sodium Chloride | 15 | 15 | Under 11 | $45.3 |
| Mesalamine Generic | 14 | 34 | Under 11 | $16K |
| Prednisone Generic | 14 | 14 | Under 11 | $213 |
| Stelara Ustekinumab | 13 | 24 | Under 11 | $422K |
| Motegrity Prucalopride Succinate | 13 | 30 | Under 11 | $15K |
| Zenpep Lipase/Protease/Amylase | 11 | 15 | Under 11 | $17K |
| Dicyclomine Hcl Generic | 11 | 22 | Under 11 | $300 |
Brand drugs: 222 claims; generic drugs: 233 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Jonathan P Terdiman $81.42 ($81.42 in general payments such as food, travel and fees) from 2 companies. The largest payer was PENTAX of America, Inc. with $51.02.
| Company | Payments | Amount |
|---|---|---|
| PENTAX of America, Inc. | 1 | $51.02 |
| Pfizer Inc. PFE | 1 | $30.4 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.